Skip to Content

Treatment of Severe Atopic Dermatitis (AD)

A new area of treatment options makes it possible to choose evidence-based drugs with a more favorable risk/benefit profile for patients with atopic dermatitis. According to Dr. Pedro Mendes-Bastos, we first must select the right, and most severely affected, patients. Secondly, we are to choose between drugs. Get his elaboration in this EADV 2022 MEDtalk.

Pedro Mendes-Bastos

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Back to top